The siRNA silenced VEGF gene expression, inhibiting tumor growth in glioblastoma-astrocytoma U-87 MG cells and zebrafish xenografts, demonstrating a promising approach for targeted brain cancer therapy. The gene discussed is VEGFA; the disease is neoplasm.